Literature DB >> 15746433

Pneumocystis cell wall beta-glucans stimulate alveolar epithelial cell chemokine generation through nuclear factor-kappaB-dependent mechanisms.

Scott E Evans1, Peter Y Hahn, Frances McCann, Theodore J Kottom, Zvezdana Vuk Pavlovic', Andrew H Limper.   

Abstract

Exuberant inflammatory responses are associated with respiratory failure during Pneumocystis pneumonia. Alveolar epithelial cells (AECs) promote Pneumocystis attachment and proliferation, but also contribute prominently to host cytokine-mediated inflammation during pneumonia. Recent investigations indicate that AECs produce macrophage inflammatory protein-2 (MIP-2) and tumor necrosis factor-alpha (TNF-alpha) following challenge with Pneumocystis carinii. Nuclear factor-kappaB (NF-kappaB) is a ubiquitous transcription factor critical for regulation of proinflammatory cytokine expression. Herein, we assess rat AEC NF-kappaB responses to challenge with a P. carinii beta-glucan cell wall component (PCBG). Prominent nuclear translocation of p65 NF-kappaB was demonstrated following PCBG challenge. NF-kappaB activation was in part mediated through Protein Kinase C (PKC) signaling pathways. PCBG challenge of AECs was also shown to induce MIP-2 and TNF-alpha mRNA production, a response that was ameliorated by NF-kappaB inhibition. MIP-2 protein expression was also dramatically increased by PCBG challenge, in a manner that was significantly attenuated by both PKC and NF-kappaB inhibition. The data further demonstrate that AEC chemokine responses were not mediated by the recently described dectin-1 receptor, but instead involved participation of cell surface lactosylceramide. These data support a significant role for AECs in host responses during Pneumocystis pneumonia, and further indicate that beta-glucan induces inflammatory cytokine production through NF-kappaB-dependent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15746433      PMCID: PMC2715319          DOI: 10.1165/rcmb.2004-0300OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  47 in total

1.  Beta-glucan from Pneumocystis carinii stimulates TNF alpha release from alveolar macrophages.

Authors:  R Vassallo; J Standing; A H Limper
Journal:  J Eukaryot Microbiol       Date:  1999 Sep-Oct       Impact factor: 3.346

2.  An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes.

Authors:  G Sweeney; R Somwar; T Ramlal; A Volchuk; A Ueyama; A Klip
Journal:  J Biol Chem       Date:  1999-04-09       Impact factor: 5.157

3.  Pneumocystis carinii major surface glycoprotein induces interleukin-8 and monocyte chemoattractant protein-1 release from a human alveolar epithelial cell line.

Authors:  T L Benfield; B Lundgren; J H Shelhamer; J D Lundgren
Journal:  Eur J Clin Invest       Date:  1999-08       Impact factor: 4.686

4.  Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia.

Authors:  T W Wright; F Gigliotti; J N Finkelstein; J T McBride; C L An; A G Harmsen
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

5.  Tumor necrosis factor-alpha mediates lipopolysaccharide-induced macrophage inflammatory protein-2 release from alveolar epithelial cells. Autoregulation in host defense.

Authors:  A M Xavier; N Isowa; L Cai; E Dziak; M Opas; D I McRitchie; A S Slutsky; S H Keshavjee; M Liu
Journal:  Am J Respir Cell Mol Biol       Date:  1999-10       Impact factor: 6.914

6.  Pneumocystis carinii inhibits cyclin-dependent kinase activity in lung epithelial cells.

Authors:  A H Limper; M Edens; R A Anders; E B Leof
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

7.  Inhibition of NF-kappaB activation by pyrrolidine dithiocarbamate prevents In vivo expression of proinflammatory genes.

Authors:  S F Liu; X Ye; A B Malik
Journal:  Circulation       Date:  1999-09-21       Impact factor: 29.690

8.  Stretch induces cytokine release by alveolar epithelial cells in vitro.

Authors:  N E Vlahakis; M A Schroeder; A H Limper; R D Hubmayr
Journal:  Am J Physiol       Date:  1999-07

9.  The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 and alpha1-anti-chymotrypsin synthesis in astrocytes by preventing degradation of IkappaB-alpha.

Authors:  B L Fiebich; T J Hofer; K Lieb; M Huell; R D Butcher; G Schumann; K Schulze-Osthoff; J Bauer
Journal:  Neuropharmacology       Date:  1999-09       Impact factor: 5.250

10.  Chemokine gene expression during Pneumocystis carinii-driven pulmonary inflammation.

Authors:  T W Wright; C J Johnston; A G Harmsen; J N Finkelstein
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

View more
  52 in total

1.  Alveolar macrophages in neonatal mice are inherently unresponsive to Pneumocystis murina infection.

Authors:  Cathryn Kurkjian; Melissa Hollifield; J Louise Lines; Amy Rogosky; Kerry M Empey; Mahboob Qureshi; Stephen A Brown; Beth A Garvy
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

Review 2.  Epithelial cells and innate antifungal defense.

Authors:  G Weindl; J Wagener; M Schaller
Journal:  J Dent Res       Date:  2010-04-15       Impact factor: 6.116

3.  Chitinases in Pneumocystis carinii pneumonia.

Authors:  Leah R Villegas; Theodore J Kottom; Andrew H Limper
Journal:  Med Microbiol Immunol       Date:  2012-04-26       Impact factor: 3.402

4.  Fungal allergen β-glucans trigger p38 mitogen-activated protein kinase-mediated IL-6 translation in lung epithelial cells.

Authors:  Wendy A Neveu; Edgar Bernardo; Jenna L Allard; Viswas Nagaleekar; Matthew J Wargo; Roger J Davis; Yoichiro Iwakura; Laurie A Whittaker; Mercedes Rincon
Journal:  Am J Respir Cell Mol Biol       Date:  2011-06-03       Impact factor: 6.914

Review 5.  Innate immunity in the respiratory epithelium.

Authors:  Dane Parker; Alice Prince
Journal:  Am J Respir Cell Mol Biol       Date:  2011-02-17       Impact factor: 6.914

Review 6.  Inhaled innate immune ligands to prevent pneumonia.

Authors:  Scott E Evans; Michael J Tuvim; Cory J Fox; Nidhi Sachdev; Leonid Gibiansky; Burton F Dickey
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

Review 7.  Current understanding of Pneumocystis immunology.

Authors:  Michelle N Kelly; Judd E Shellito
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

8.  Evidence for Proinflammatory β-1,6 Glucans in the Pneumocystis carinii Cell Wall.

Authors:  Theodore J Kottom; Deanne M Hebrink; Paige E Jenson; Gunnar Gudmundsson; Andrew H Limper
Journal:  Infect Immun       Date:  2015-04-27       Impact factor: 3.441

9.  Src kinase-targeted anti-inflammatory activity of davallialactone from Inonotus xeranticus in lipopolysaccharide-activated RAW264.7 cells.

Authors:  Y G Lee; W M Lee; J Y Kim; J Y Lee; I-K Lee; B-S Yun; M H Rhee; J Y Cho
Journal:  Br J Pharmacol       Date:  2008-05-05       Impact factor: 8.739

10.  Biofilm formation by Pneumocystis spp.

Authors:  Melanie T Cushion; Margaret S Collins; Michael J Linke
Journal:  Eukaryot Cell       Date:  2008-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.